Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/553
SARS-CoV-2 and COVID-19
WANG-HUEI SHENG
Wen-Chien Ko
PO-REN HSUEH
Yhu-Chering Huang
Acceso Abierto
Atribución-NoComercial-SinDerivadas
https://doi.org/10.1016/j.jmii.2020.03.033
Since December 2019, an outbreak of a novel coronavirus (2019-nCoV) emerged in Wuhan City, Hubei Province, China. The World Health Organization (WHO) had announced a new name for the new coronavirus disease 2019 (COVID-19) on February 11, 2020 and potential of pandemic outbreak of COVID-19 on March 11, 2020. By March 26, 2020, more than 460,000 confirmed cases and 20,834 confirmed deaths due to COVID-19 had been reported from 173 countries worldwide. In this special issue, the clinical manifestations of COVID-19, infection control measures by hospital setting and government actions were discussed. In recent two decades, two known zoonotic coronavirus outbreaks, the severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) were associated with severe pneumonia. Lee et al. compared the three coronavirus outbreaks.1 The already available data suggested that the 2019-nCoV may be less pathogenic than the MERS-CoV and SARS-CoV. However, the rapidly increasing number of COVID-19 cases suggests that this virus might transmit more effectively among humans compared to prior strains of coronavirus and that mild illness might be quite common in infected individuals. These features confer a high pandemic potential of COVID-19.
Journal of Microbiology, Immunology and Infection
2020
Preimpreso
https://www.sciencedirect.com/science/article/pii/S1684118220300931?via%3Dihub
Inglés
Epidemia COVID-19
Investigadores
VIRUS RESPIRATORIOS
Aparece en las colecciones: Artículos científicos

Cargar archivos:


Fichero Tamaño Formato  
SARS-CoV-2 and COVID-19.pdf216.58 kBAdobe PDFVisualizar/Abrir